The human mammary gland is capable of de novo synthesis of glucose and galactose (hexoneogenesis); however, the carbon source is incompletely understood. In this study, we investigated the role of acetate, glutamine, lactate and glycerol as potential carbon sources for hexoneogenesis. Healthy breastfeeding women were studied following a 24-h fast on two occasions separated by 1-3 wk. Five women were infused with [U-
galactose; lactose synthesis; gluconeogenesis; pentose phosphate pathway; stable isotopes GC-MS WE PREVIOUSLY DEMONSTRATED (26) that plasma glucose is the predominant but not the exclusive carbon source of milk lactose (80% during the fed state and 60% following 24 h of fasting). Thus, the mammary gland is capable of de novo synthesis of glucose and galactose, a process we termed hexoneogenesis. During feeding, hexoneogenesis contributes 20% of the carbon in lactose (10 and 30% of glucose and galactose, respectively) (20, 26, 27) . Over a 14-to 42-h fast, hexoneogenesis increases to account for ϳ40% of lactose production (ϳ30% of glucose and ϳ50% of galactose) (18, 20, 21, 26, 27) . However, the precursor carbon source for hexoneogenesis remains largely unknown.
We hypothesize that those traditional gluconeogenic substrates for hepatic glucose production will also serve as precursors for hexoneogenesis. Lactate, a predominant gluconeogenic precursor in humans, accounts for 50 -70% of the total gluconeogenic flux in normal humans (3, 12) . Another significant precursor of glucose synthesis (particularly in the kidney) is glutamine, which together with glutamic acid are the most abundant amino acids in the body (7) and in breast milk, since together they constitute 20% of total amino acids (5) .
We (26) previously reported that glycerol (using [2-13 C]glycerol) contributed 14% to the production of galactose synthesized within the mammary gland but little or none to glucose in lactose. We (17) and others (10, 11, 14, 15, 23, 30) have reported that in humans and other mammalian species the mammary gland is an exceptionally active organ in metabolizing triglycerides and fatty acids. As a consequence, the release of glycerol secondary to the transport and hydrolysis of plasma triglycerides could provide substantial substrate for hexoneogenesis. However, in our previous study we did not account for the potential dilution of the glycerol tracer within the mammary gland (17) as a result of glycerol derived from hydrolysis of triglycerides. This dilution most likely leads to an underestimation of the fraction of hexoneogenesis from glycerol.
Accordingly, the present study was undertaken to determine the contributions of lactate, glutamine, and glycerol to the process of hexoneogenesis in fasted lactating women. We used labeled acetate to control for the incorporation of 13 CO 2 derived from the oxidation of [ 13 C 2 ]acetate into glucose and galactose. We chose to perform these studies in the fasting state, in which the hexoneogenesis represents ϳ50% of lactose.
MATERIALS AND METHODS

Materials
␤-Galactosidase (Escherichia coli, grade VIII, 740,000 U/g), BaOH (0.3 N), ZnSO4 (0.3 N), 1-propanol, NH4OH, acetyl chloride, and HFBA were purchased from Sigma-Aldrich (St. Louis, MO). [1- 
Study and Protocol Design Subjects
The study was approved by the Institutional Review Board for Human Subject Research at Baylor College of Medicine and the General Clinical Research Center (GCRC) in Houston, TX. Subjects were studied following obtaining written consent. Subjects had to be of normal weight, healthy, 6 -12 wk post partum, and exclusively breastfeeding a healthy normal infant. Six to 12 wk postpartum was selected since the uterus has involuted, lactation is well established, the mothers are comfortable with breastfeeding and breast pumping, and the infants have thoroughly adapted to exclusive breastfeeding. For the lactate and glutamine studies, five normal lactating women (27 Ϯ 2 yr, 68 Ϯ 3 kg, and BMI 26 Ϯ 1 kg/m 2 ) were enrolled, whereas for the glycerol and acetate studies five additional normal lactating women (29 Ϯ 2 yr, 66 Ϯ 4 kg, and BMI 26 Ϯ 1 kg/m 2 ) were enrolled. Previously published data (26) from six normal women (27 Ϯ 3 yr, 69 Ϯ 5 kg, and BMI 26 Ϯ 3 kg/m 2 )were utilized for comparison. The studies were done at a window of 6 -12 wk post partum. All of the volunteers underwent a general physical examination and had normal hemoglobin and screening studies for liver and renal function and a negative pregnancy test before being accepted into the study. One set of subjects was infused with [U- 13 C]lactate on one occasion, and [1,2- 13 C2]glutamine on the other. The other set of subjects was infused with [U- 13 C]glycerol on one occasion and [1,2-
13 C2]acetate on the other. For any individual, the studies were separated by 1-3 wk, and the infusions of specific labeled substrates were performed in a random order.
Additionally, breast milk and plasma samples derived from previous published studies (19, 20) were analyzed for isotopomer distributing analysis under similar study conditions except that these studies were preceded by a 7-day high-carbohydrate/low-fat diet (HC) or low-carbohydrate/high-fat diet (HF) and the subject received an infusion of only [U- 13 C]glucose during 12-to 14-h fasting (19, 20) .
Study Protocols
The subjects were instructed to consume a diet containing ϳ50% carbohydrate, ϳ15% protein, and ϳ35% fat a week prior to admission. The subject and her infant were admitted to the GCRC on the evening prior to the study. Baseline blood and breath samples were obtained. At 6:00 PM, and they were fed a supper meal (10 kcal/kg) having the same macronutrient distribution as prior to study. They were subsequently fasted, except for water, until the end of the study, at 6:00 PM the next day.
At midnight, three intravenous catheters were introduced into the mother's antecubital fossa or forearm vein under Ela-Max cream analgesia (Ferndale Laboratories, Ferndale, MI), one for isotope infusion, one for blood sampling in the contralateral arm, and one for back-up for blood sampling in the same arm. The veins were kept open by the slow infusion of 0.9% NaCl. Beginning at midnight, the subjects received a constant infusion of either [U- 13 The subjects breastfed their infants from both breasts at ϳ3-h intervals, after which, milk (2.5 ml) was collected from both breasts simultaneously using a standard electric breast pump (Playtex Embrace, Dover, DE) into sterile milk bottles (Ross Products, Columbus, OH). The infants were weighed using an electronic scale (Scale-tronix Pediatric Scale 4802, Wheaton, IL) before and immediately after breastfeeding to determine the volume of milk ingested according to Neville et al. (22) . Indirect calorimetry was performed every 3 h until the end of the study. Blood (6 ml) and breath samples were collected before starting the infusion and subsequently every 3 h from 3:00 AM to 3:00 PM and then hourly during the last 3 h of the study. Samples were immediately placed on ice. Blood samples were centrifuged at 3,000 rpm for 10 min at 4°C, and the plasma was separated and transferred to a new vial and then stored at Ϫ80°C until further analyses. In addition, an aliquot of blood was immediately centrifuged and analyzed for plasma glucose at bedside, using the Biochemical Analyzer, model 2700 Select (Yellow Springs Instruments, Yellow Springs, OH; YSI). Milk samples from both breasts were combined, and a 2.5-ml aliquot was transferred to a new tube and stored at Ϫ80°C. Breath samples were collected by facemask through a one-way Phillips valve into a sealed 3-L anesthesia bag, immediately aspirated into 10-ml vacuum tubes, and stored at room temperature until analysis. At the end of the study, the subjects were given a light meal and were then discharged from the GCRC. The protocol using [2-13 C]glycerol infusion is published elsewhere (27) .
Analytic Methods
Substrate concentration. Glucose, lactose, and lactate in milk and plasma were determined as previously reported (20) . Milk protein and fat concentrations were measured as previously reported (21 13 C in the glucose isotopomers in plasma and milk were performed using the acetic anhydride derivative (26) . To investigate the position and distribution of 13 C labeling on plasma and milk hexoses during both lactate and glycerol infusions, the optimized aldonitrile pentaacetate derivative using GC-MS and standards of 13 C3-labeled glucose (1-3-13 C3 and 4 -6-13 C3) was utilized (2). The analyses were performed using SP17-1 capillary columns, and conditions for the GC-MS were as follows: temperature program 70°C for 1 min, a temperature ramp at 25°C/min up to 320°C followed by a 6-min hold, monitoring in the EI mode for ions of m/z 242-245 allowing detection of the incorporation of 13 C into 1-3 carbons, while m/z 217-220 to detect the incorporation of 13 C into 4 -6 carbons. The triacetate derivative of free glycerol in plasma and milk was prepared using acetic anhydride as described previously (19) . Additionally, breast milk triglycerides were hydrolyzed using alkaline saponification (17) and total glycerol enrichments, and concentrations were measured (26) . The pentafluorobenzyl-acetyl derivative of lactate was analyzed for the isotopic enrichments of [U- 13 C]lactate in both plasma and milk by GC-MS using an HP-5 capillary column, monitoring for ions of m/z 131-134 in the NCI mode (19) . The conditions for the GC-MS were as follows: temperature program 70°C for 1 min and a temperature ramp at 15°C/min up to 320°C followed by a 2-min hold. The heptafluorobutyric acid derivative of glutamine was analyzed for the isotopic enrichment of [1,2- 13 C2]glutamine using an HP-5 capillary column, monitoring for ions of m/z 346 -348 on the NCI mode. For the determination of milk glutamine enrichments, defatted and deproteinized samples were run through an AG-50W resin column prior to esterification and derivatization. Enrichments of acetate in plasma and milk were performed using the PFB derivative as has been described (19) . We encountered problems in detecting 13 C enrichments in milk acetate; accordingly, the M 2 enrichment of lauric acid (C12:0) was measured as described (19) and was used as a surrogate for acetate enrichment in milk (after being divided by 6, i.e., number of acetate units in C12:0 FA) (19) .
Calculations
We utilized the same calculations employed for the calculation of hexoneogenesis derived from glycerol during infusion of [2- 13 C]glycerol under fasting conditions (26) .
Standard product precursor relationships were calculated. The percentage of product, i.e., glucose and galactose in milk lactose, that was derived from the precursor pool (plasma glucose), was calculated using the following equation (Eq. 1):
%milk sugar ( plasma glucose ϭ ͓͑M6͔ milk sugar/͓M 6͔ plasma glucose͒ ϫ 100 (1) where milk sugar is either the glucose or the galactose moiety in lactose. [M 6] enrichments are derived from the infusion of [M 6]glucose tracer (26) .
The contribution from glycerol to milk glucose and galactose produced from other sources than plasma glucose via processes within the breast (%milk sugar ( glycerol) was calculated using Eq. 2: Additionally, we used the following model (total 13 C model) for the estimating the percent contribution of labeled substrate into glucose in systemic circulation (i.e., via gluconeogenesis).
During lactate infusion, the percentage of product, i.e., glucose in plasma that was derived from the precursor pool i.e., plasma lactate,
where M1, M2, and M3 are the enrichments of the plasma glucose and lactate isotopomers ([M 1], [M2], and [M3], respectively) as calculated using the matrix (9), and 6 and 3 are the numbers of carbons in glucose and lactate molecules, respectively.
We applied the same model and principles for glycerol during the infusion of [U- 13 C]glycerol as a precursor for plasma glucose. We also used a similar approach for glutamine and acetate, with the exception that glutamine and acetate have 5 and 2 carbons (not 3 as in case of lactate and glycerol).
The total rate of appearance (R a total) and oxidation rates of different substrates during different infusions have been obtained using standard formulae described for glucose previously (27) .
Statistical Analyses
Substrate concentrations and the enrichment data from each subject were averaged for the last 6 h of the infusion (18 -24 h of fasting). All data are expressed as means Ϯ SE. Substrate concentrations, rates of appearance, enrichments, and contributions to gluconeogenesis and hexoneogenesis were compared using paired Student's t-test (within the same subjects) and/or nonpaired Student's t-test (between subjects) using SPSS program. Significance was set as P Ͻ 0.05.
RESULTS
Milk Production and Composition
We have generated quantitative data from the women who were studied in the glycerol/acetate infusions. Among these five women, milk volume ranged between 600 and 1,040 ml/day with an average of 862 Ϯ 90 ml/day. Milk composition expressed as concentration (g/dl) and production (g/feeding) of macronutrients of lactose, fat, and proteins during the 24-h stay at the GCRC are depicted in Fig. 1 . All measured parameters, except for lactose concentration, decreased slightly over the fast duration (repeated-measures ANOVA, P Ͻ 0.05). Additionally, we found a very strong relationship between daily milk volume and daily lactose production among these five women (r ϭ 0.99), supporting the hypothesis that lactose production is a primary determinant of milk volume.
[1, 2-13 C 2 ]acetate infusion. During the infusion of [1,2-13 C 2 ]acetate, the enrichment of M 2 acetate in plasma was 7.94 Ϯ 0.36 whereas that estimated in milk (as derived from the enrichment of milk lauric acid) was 2.88 Ϯ 0.29%, ( Table 1) . Systemic acetate R a was 6.5 Ϯ 0.3 mol·kg Ϫ1 ·min Ϫ1 , 60 Ϯ 2% of which was oxidized. The M 2 enrichments of plasma glucose and milk glucose and galactose were 0.13 Ϯ 0.02, 0.07 Ϯ 0.01 and 0.07 Ϯ 0.01%. Enrichment of M 1 of plasma glucose and milk glucose and galactose were three-to sixfold higher than that of their respective M 2 value (Table 1) . Lactate concentrations in plasma were about sevenfold higher in plasma than those in milk (780 Ϯ 170 vs. 120 Ϯ 65 mol/l, P Ͻ 0.01).
According to either Eq. 2 or Eq. 3, acetate contributed nothing to hexoneogenesis within the mammary gland (Fig. 2) . Utilizing the total 13 C model (Eq. 4), acetate contributed to an estimate of 1.3 Ϯ 0.2% of total glucose appearing in the circulation.
[U- 13 C 3 ]lactate infusion. During the infusion of [U- 13 C]lactate, the M 3 enrichment of lactate in plasma and milk were 1.99 Ϯ 0.2 and 1.29 Ϯ 0.13%, respectively (Table 1) . Systemic lactate R a in plasma was 20 Ϯ 2 mol·kg Ϫ1 ·min Ϫ1 , of which Fig. 1 . Milk volume and macronutrients (lactose, fat, and protein) concentration (g/dl) and production (g/feeding) over the studied day of inpatient at the GCRC. Data are derived from the 5 women who were studied during labeled glycerol and acetate infusions. Data for each of the 5 women were averaged for the 2 days of studies. Except for milk lactose concentration, all other measured parameters decreased with fasting duration (P by repeatedmeasures ANOVA Ͻ 0.05).
49 Ϯ 3% was oxidized. The M 3 enrichments of plasma glucose and milk glucose and galactose were 0.38 Ϯ 0.08, 0.23 Ϯ 0.06, and 0.25 Ϯ 0.04%, respectively. However, M 1 and M 2 enrichments of plasma glucose and milk glucose and galactose were 1.5-2.5 times higher (P Ͻ 0.05) than those of their respective M 3 values (Table 1) . According to the analyses of aldonitrile pentaacetate derivative of hexoses, the ratio of 13 C carbon enrichment of the major isotopomer (M 2 ) on the first three carbons (1-3)/M 2 on the second three carbons (4 -6) in plasma glucose, milk glucose, and milk galactose were essentially identical (P Ͼ 0.05; 1.06 Ϯ 0.13, 1.05 Ϯ 0.12 and 1.01 Ϯ 0.13, respectively).
According to either Eq. 2 or Eq.3, lactate contributed essentially nothing (Ϫ1 Ϯ 1% of glucose and 2 Ϯ 1% galactose) to hexoneogenesis within the mammary gland (Fig. 2) . Utilizing the total 13 C model (Eq. 4), lactate contributed to an estimate of 22 Ϯ 4 of total glucose appearing in the circulation.
[ , 62 Ϯ 4% of which was oxidized. The M 2 enrichment of plasma glucose and milk glucose and galactose were 0.06 Ϯ 0.01, 0.06 Ϯ 0.01, and 0.05 Ϯ 0.01%, respectively, and were three-to fourfold lower (P Ͻ 0.05) than their respective M 1 values ( Table 1) .
As with acetate and lactate (using Eqs. 2 or 3), glutamine contributed essentially nothing (0.3 Ϯ 2.1% of glucose and 1.4 Ϯ 1.2% galactose) to hexoneogenesis within the mammary gland (Fig. 2) . Utilizing the total 13 C model (Eq. 4), glutamine contributed to 2.5 Ϯ 0.5 of total glucose appearing in the circulation.
[U- 13 C]glycerol infusion. During the infusion of [U- 13 C]glycerol, the M 3 enrichments of free glycerol in plasma and milk were 5.76 Ϯ 0.85 and 1.55 Ϯ 0.25%, respectively ( Table 1) . The enrichment of M 3 glycerol in hydrolyzed milk during the last 6 h of infusion was 1.45 Ϯ 0.30 and did not differ from that of free milk glycerol (P Ͼ 0.05). Plasma free glycerol concentration was ϳ20% of that of free milk glucose (103 Ϯ 22 vs. 470 Ϯ 50 mol/l, P Ͻ 0.01). However, the concentration of total milk glycerol was ϳ25 Ϯ 4 mmol/l (i.e., ϳ200-and ϳ50-fold higher than free glycerol in plasma and milk, respectively).
Systemic glycerol R a was 5.5 Ϯ 0.9 mol·kg Ϫ1 ·min
Ϫ1
, 47 Ϯ 3% of which was oxidized. The M 3 enrichment of plasma glucose and milk glucose and galactose were 0.87 Ϯ 0.04, 0.74 Ϯ 0.05, and 0.77 Ϯ 0.05%, respectively and were four to five times higher than their respective M 1 or M 2 values (Table  1) . According to the analyses of aldonitrile pentaacetate derivative of hexoses, the ratio of M 3 enrichment on the second three carbons (4 -6)/M 3 on the first three carbons (1-3) on the galactose molecule was significantly higher (P Ͻ 0.05; 1.22 Ϯ 0.05) than those in plasma glucose (1.05 Ϯ 0.03) and milk glucose (1.07 Ϯ 0.02).
With Eq. 2, glycerol contributed 3 Ϯ 1% of glucose and 18 Ϯ 2% of galactose synthesized de novo within the mammary gland (Fig. 2) . Utilizing the dilution factor (M 3 glycerol in plasma/M 3 glycerol in milk, Eq. 3), glycerol contributed 10 Ϯ 2 and 69 Ϯ 8% to hexoneogenesis of milk glucose and galactose, respectively. Utilizing the total 13 C model (Eq. 4), glycerol contributed to 11 Ϯ 1 of total glucose appearing in the circulation.
[ Ϫ1 . The M 1 enrichment of plasma glucose and milk glucose and galactose were 7.3 Ϯ 0.7, 4.9 Ϯ 0.6, and 6.0 Ϯ 0.6%, respectively (Table 1) . Using Eq. 2, glycerol contributed Ϫ1 Ϯ 1% of glucose and 15 Ϯ 2% of galactose synthesized within the mammary gland (Fig. 2) . However, utilizing the dilution factor (M 1 glycerol in plasma/M 1 glycerol in milk, Eq. 3), glycerol contributed Ϫ4 Ϯ 3 and 65 Ϯ 7% to hexoneogenesis of milk glucose and galactose in lactose, respectively (Fig. 2) .
[U- 13 C]glucose infusion. From our pervious study of an infusion of [U- 13 C]glucose alone following an overnight fast on both high-carbohydrate and high-fat diets (19, 20) , the mass isotopomer distribution analyses (MIDA) utilizing the pentaacetate derivative of plasma and milk hexoses indicated lower (P Ͻ 0.01) M 6 but higher (P Ͻ 0.05) M 1 , M 2 , M 3 , and M 4 in galactose compared with glucose in either plasma or milk ( Table 2) .
DISSCUSSION
Our present study demonstrated that glycerol is an important source for systemic gluconeogenesis but a primary source of substrate for mammary gland hexoneogenesis. Using our previous isotopic model (26) , the results of de novo synthesis of galactose during [U- 13 C]glycerol infusion are comparable to those we previously reported using [2- 13 C]glycerol (18 Ϯ 2 vs. 14 Ϯ 2%, respectively, NS). The ratios of the milk to plasma glycerol enrichments (4.3 Ϯ 0.5 and 4.1 Ϯ 0.8, respectively) were essentially identical, and the free milk concentrations four-to fivefold higher in milk than in plasma, in both studies. We believe that these findings can be explained by the high rates of transport and hydrolysis of acylated glycerols (mono, di, and tri) into the mammary gland, liberating free glycerol into the intracellular space of the mammary epithelial cell (MEC) (17) . In support of our speculation, earlier work by West et al. in the mammary gland of the goat (30) reported extensive hydrolysis of plasma triglycerides during uptake into the mammary epithelial cell. Similar findings were observed in guinea pigs (14) and in rats (15) , highlighting the role of the lipoprotein lipases in the hydrolysis of triglycerides at the MEC membrane (10, 11, 14, 15, 23, 30 (twice as high) than the [ 14 C]fatty acid, indicating a more rapid and selective transfer of glycerol into milk (30) .
Low-carbohydrate/high-fat diet
We analyzed the glycerol enrichments and concentrations in hydrolyzed milk as well as the free milk pool of glycerol. Our data comparing the enrichments of M 3 glycerol in the hydrolyzed milk lipids to the free glycerol in milk was 96 Ϯ 2%, indicating that the blood triglycerides were nearly completely hydrolyzed to fatty acids and glycerol in the process of triglyceride uptake. The liberated and transported glycerol is phosphorylated by glycerol kinase yielding glycerol-3-P. Glycerol-3-P can then be acylated to form the triglyceride backbone or converted to dihyroxyacetone-P by glycerol-3-P dehydrogenase and can flow down the glycolytic pathway for oxidation or up the pathway to form hexose moieties. On the basis of our data, we believe that the more likely fate of glycerol in the MEC is the latter and would in part account for the labeling of galactose for milk lactose. Thus, the precursor pool for de novo galactose synthesis must be that reflected in the diluted glycerol within the mammary epithelial cells (i.e., milk glycerol). Using this dilution, we estimate that glycerol contributes to ϳ10 and 70% of the de novo synthesis of glucose and galactose, respectively, within the mammary epithelial cells and thus constitutes the primary source of substrate contributing to hexoneogenesis (details on the proposed mechanisms will follow below).
In the present study, we demonstrate that glycerol contributes ϳ10 -15% of total glucose R a [i.e., 20 -30% of total gluconeogenesis, assuming that gluconeogenesis represents half of glucose Ra (20)]. Our estimates for lipolysis from the glycerol kinetics as well as the contribution from glycerol to glucose production in lactating women are higher than those previously reported for healthy nonlactating subjects (1). In overnight-fasted healthy men, glycerol R a was 3.11 Ϯ 0.44 mol·kg Ϫ1 ·min Ϫ1 , of which 36% was converted to glucose, accounting for 4.5% of total glucose production (1). After 62-86 h of fasting, glycerol R a increased to 5.32 Ϯ 0.58 mol·kg Ϫ1 ·min Ϫ1 , and 68% of glycerol was converted to glucose and accounted for 21.6% of total glucose production (1). The higher rate of lipolysis in lactating women could be one of the mechanisms to accommodate for the extra glucose demands of fasting during lactation (18) .
The present studies demonstrate that lactate plays essentially no role as substrate in hexoneogenesis within the mammary gland. Moreover, the concentration of lactate in milk was 20% of that in plasma, implying little direct transport of lactate into the mammary gland. These findings are in agreement with earlier in vitro reports in bovine mammary tissue (25) indicating no detectable utilization of [U-
14 C]lactate for lactose synthesis. However, the present study emphasizes the role of lactate as an important precursor for hepatic gluconeogenesis. Utilizing our total 13 C labeling model (Eq. 4), lactate accounted for 22% of glucose total R a and ϳ45% of substrate for gluconeogenesis [assuming that gluconeogenesis constitutes ϳ50% of glucose production after 14-h fasting (13, 20) ]. This finding is in agreement with previous reports from our laboratory (16) and others' (3, 6) . However, we acknowledge that this calculation may overestimate the hepatic fractional synthesis of glucose from lactate since we used not only M 3 (indicator of direct lactate contribution) but also utilized the M 1 and M 2 labeled moieties. These later isotopomers are products of both TCA and Cori cycle activities.
The systemic R a of lactate found in the present study is higher (20.8 Ϯ 1.8 vs. 12.7 Ϯ 0.8 mol·kg Ϫ1 ·min Ϫ1 , P Ͻ 0.01) than those in 15-h fasting nonlactating subjects (3). However, the oxidation rates in the lactating vs. nonlactating subjects (3) were not different (10.2 Ϯ 1.3 vs. 7.6 Ϯ 0.6 mol·kg Ϫ1 ·min Ϫ1 , P ϭ 0.07). Thus, the estimated nonoxidized (uptake) rate was twice as high in the lactating subject (10.0 Ϯ 1.0 vs. 4.8 Ϯ 0.7 mol·kg Ϫ1 ·min Ϫ1 , P Ͻ 0.001). These observations indicating higher rates of lactate turnover and uptake in the postabsorptive lactating vs. the nonlactating women and remain to be fully explained (18) . However, the site of utilization, based on our findings must be in tissues other than the mammary gland.
As we anticipated, [ 13 C 2 ]acetate contributed little or nothing to either hexoneogenesis or gluconeogenesis (29) . These findings in humans are different from those found in ruminants, reflecting differences in substrate availabilities and utilization among different species (4) . Studies utilizing acetate tracers in bovine reported 14 C labeling exclusively and specifically in the galactose, but not glucose, moiety of the lactose (24, 34, 35) . The flux of acetate in lactating women in our study is comparable to those reported in healthy, physically active men at rest, during exercise, or during recovery [365-415 mol/min, i.e., ϳ5 mol·kg Ϫ1 ·min Ϫ1 (28)]. However, the 13 C recovery in 13 CO 2 in our study (60%) was lower than those reported in men [75 or 100% during rest or exercise (28) ]. This difference may reflect the utilization of acetate in the process of de novo fatty acid synthesis within the mammary gland (19) .
Despite significant plasma glutamine enrichment of M 2 isotopomer (ϳ6%), little or no enrichment was observed in either the glucose or galactose derived from milk lactose. Therefore, we conclude that glutamine is not a precursor for hexoneogenesis under the conditions of these studies. Our data are consistent with those in lactating bovine mammary tissue showing no detectable utilization of [U-
14 C]glutamate in milk lactose synthesis (25) . In the present study, the estimated contribution of glutamine was only ϳ2% of the total systemic glucose. This value, however, is lower than the 5% reported after 12-15 h of fasting (3) or 8 and 16% following 14 and 42 h of fasting (7), respectively. We speculate that the lower values obtained in the present study are due to the position of the labeled carbons on the glutamine molecule. In the liver, the position of the 13 C labeling in [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glutamine utilized in our previous study (7) is primarily incorporated into glucose via the glutamine entering the TCA cycle at the level of ␣-ketoglutarate (a potential gluconeogenic substrate), which has a lower chance of loss of 13 C label through the TCA cycle. However, in the case of [1, 2-13 C 2 ]glutamine used in the present study, the labeled carbon at position 1 is lost though conversion of ketoglutarate to succinate, whereas the carbon on position 2 has only a 50% chance of being lost. Thus, we may have significantly underestimated the contribution of glutamine to systemic glucose production.
To elucidate the mechanism of galactose synthesis within the mammary gland, two potential pathways, including the regular gluconeogenic (reversal Embden-Meyerhof) pathway and the pentose phosphate pathway, could result in the labeling of glycerol and are of relevance to our study. We would like to draw our readers' attention to an elegant series of publications between 1957 and 1965 focusing on the issue of galactose synthesis using the bovine animal model and infusions of different 14 C-labeled substrates (8, 24, (31) (32) (33) (34) (35) . The distribution of 14 C in milk lactose following intravenous injection of labeled of [1- 14 C]acetate indicated that the glucose moiety of lactose originates from free glucose (in equilibrium with blood glucose) and the galactose from hexose phosphates formed within the mammary gland (24) . To eliminate the contribution of 14 C-labeled glucose from the liver, the cow udder was perfused with [1- 14 C]acetate in vitro (34) or injected directly with [1- 14 C]acetate into the pudic artery in vivo (35) . They observed that the 14 C was found almost exclusively in the galactose, but not in the glucose, moiety of the lactose. The authors concluded that the acetate is converted in a direct route to galactose in the udder via the TCA cycle to hexose phosphate (not to free glucose) (35) .
When [l,3-14 C]glycerol was injected unilaterally into one pudic artery of a cow (32) , the distribution of l4 C in the six carbons of blood glucose was very similar to that of the glucose moiety in lactose on the noninjected and, to a large extent, the injected side of the udder. As with acetate injection, the authors suggested that the glucose moiety arises either from free glucose or from a hexose phosphate pool in which there is little randomization of the l4 C in the carbon chain of the hexose phosphate. However, the galactose moiety on the injected side had a ninefold increase in l4 C labeling than did the blood glucose and a completely different l4 C distribution pattern since C-4 and C-6 of galactose on the injected side contained 90% of the total l4 C labeling. Should galactose be derived via the gluconeogenic process, either C-1 and C-3 or C-4 and C-6 should have contained equal labeling (i.e., 50% each). The authors proposed that these positions are labeled as a result of the transaldolase exchange reaction (but not through a net synthesis) via the pentose phosphate pathway (32) . They further compared the distributions of 14 C in the glucose and galactose moieties of milk lactose from cows' udders perfused with blood containing [1- 14 C]-, [2-14 C]-, and [6- 14 C]glucose. On the basis of these data, they concluded that the glucose moiety primarily arose from free glucose but that the galactose came, in part, from hexose phosphate intermediates as a result of the pentose phosphate pathway activity (33) . They estimated the proportional glucose utilization in the mammary gland: 1) 20 -30% via the pentose cycle, 2) ϳ10% by the Embden-Meyerhof pathway, and 3) 60 -70% converted into lactose (33) . Interestingly, the authors detected 14 C from [6-14 C]glucose in C-1 of galactose. This can occur only by conversion of [6- 14 C]glucose into glyceraldehyde 3-phosphate via the pentose cycle and then conversion to hexose via synthesis through the Embden-Meyerhof pathway (33) . Thus, there appears to be synthesis of galactose via the glycolytic/gluconeogenic pathway.
To explore the role of the pentose phosphate pathway in lactose synthesis in humans, we have optimized a method utilizing standards of 13 C 3 -labeled glucose ([1-3-13 C 3 ] and [4 -6-13 C 3 ]) and aldonitrile pentaacetate derivative by use of GC-MS (2). This method enabled us to discern, to some extent, the distribution of 13 C labeling of plasma and milk hexoses. The distribution of 13 C conveyed from [U- 13 C]glycerol as indicated by the ratio of M 3 enrichment on second three carbons (C-4 -C-6)/M 3 on the first three carbons (C-1-C-3) of the galactose molecule was higher (P Ͻ 0.05) (1.22 Ϯ 0.05) than in plasma glucose (1.05 Ϯ 0.03) or milk glucose (1.07 Ϯ 0.02). However, in the case of [U- 13 C]lactate infusion, the ratio of 13 C carbon enrichment of the major isotopomer (M 2 ) on C-1-C-3/M 2 on C-4 -C-6 in plasma glucose, milk glucose, and galactose were essentially identical (P Ͼ 0.05, 1.06, 1.05, and 1.01, respectively). These findings, therefore, support the role of glycerol but not lactate, as a precursor of galactose within the mammary gland. However, the higher ratio of enrichment of 13 C on C-4 -C-6/C-1-C-3 suggests a potential role of the pentose phosphatase pathway as has been proposed in a bovine model (32) . Furthermore, we have revisited our previous study of lactating women during feeding on a high-carbohydrate and high-fat diet (19, 20) . During these studies, women were infused with [U- 13 C]glucose alone to measure gluconeogenesis and hexoneogenesis following an overnight fast. Mass isotopomer distribution analysis (MIDA) indicated lower (P Ͻ 0.01) M 6 , but higher (P Ͻ 0.01) M 1 -M 4 in galactose compared with either plasma or milk glucose and again suggests the rearrangements (i.e., nonproductive isotopic exchange) of the glucose carbons into the newly synthesized galactose and supports a role of the pentose phosphate pathway. We attempted to utilize the aldonitrile pentaacetate derivative to localize the distribution of 13 C particularly in the M 3 isotopomer but were unable to do so because of the overlap between the ion clusters of different fragments when there are more than three 13 C atoms in the same hexose molecule (2) .
We would point out that there are legitimate differences between our current studies and those of in vivo infused udder with [l, 3- 14 C]glycerol (32) and perfused mammary gland studies (8, 24, (31) (32) (33) (34) (35) . These differences include species and the direct infusion of the labeled glycerol into the pudic artery. More importantly, these studies were conducted in the absorptive state and abundance of glucose. The single cow in that study (32) was fasted only during the 3-h infusion, whereas ours were performed during 24 h of fasting. Therefore, it is deemed worthy to determine how generalizable the results of the bovine model are particularly under similar conditions of lactose precursor availability (i.e., glucose).
We conclude that, following 18 -24 h of fasting in lactating women: 1) neither acetate nor glutamine plays a role as carbon substrates for either mammary hexoneogenesis or systemic gluconeogenesis; 2) lactate is a primary substrate for systemic glucose production (22 Ϯ 4% of total glucose) but is not a substrate for mammary hexoneogenesis; 3) glycerol is an important (second after lactate) substrate for systemic glucose production (ϳ11% of total); and 4), as a consequence of glycerol dilution by the action of mammary gland lipase activity, glycerol provides about one-half of the carbons for mammary hexoneogenesis (ϳ10% of glucose and ϳ70% of galactose that is synthesized de novo within the mammary gland); 5) the pentose phosphate pathway may play a role in the synthesis of galactose in the human breast; and 6) it is likely that the labeling of milk hexoses from labeled glycerol is, at least in part, the result of net synthesis, whereas the very low level of labeling of milk hexoses from labeled lactate, acetate, and glutamine are most likely the results of nonproductive isotopic exchanges. Further studies are required to quantitate the relative role of the hexoneogenesis via the reversal Embden-Meyerhof pathway vs. that of the pentose phosphate pathway.
